Li Ping

Dr. Li Ping, M.D., Ph.D., is a distinguished Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital (Tongji University School of Medicine). As a doctoral and master's supervisor, she is a leading expert in the field of hematologic malignancies, with a distinguished career dedicated to clinical practice, research, and education.

She earned her Doctor of Medical Science degree from the prestigious Nagoya University in Japan, where she also completed advanced postdoctoral research. Dr. Li specializes in the comprehensive diagnosis and treatment of various blood cancers, with a profound focus on lymphoid malignancies, including leukemias, lymphomas, and multiple myeloma. Her clinical expertise spans the entire spectrum of modern hematologic oncology, from conventional chemotherapy and hematopoietic stem cell transplantation to cutting-edge targeted therapies and pioneering immunotherapies.

A recognized pioneer in China, Dr. Li possesses exceptional skill in the full-cycle management of CAR-T (Chimeric Antigen Receptor T-cell) therapy, a revolutionary treatment for relapsed or refractory blood cancers. She actively leads and participates in numerous national and international clinical trials, bringing the most advanced therapeutic options to her patients. In addition to her clinical work, Dr. Li holds significant academic roles, serving as a committee member in several national professional societies, such as the China Anti-Cancer Association. She continues to contribute to scientific literature and guides the next generation of hematologists. Dr. Li is highly respected for her deep clinical acumen, commitment to innovative research, and dedicated, patient-centered care.